vs

Side-by-side financial comparison of Sharps Technology Inc. (STSS) and Catheter Precision, Inc. (VTAK). Click either name above to swap in a different company.

Catheter Precision, Inc. is the larger business by last-quarter revenue ($238.0K vs $83.6K, roughly 2.8× Sharps Technology Inc.). Catheter Precision, Inc. runs the higher net margin — -2427.7% vs -125963.6%, a 123535.9% gap on every dollar of revenue. On growth, Sharps Technology Inc. posted the faster year-over-year revenue change (217.9% vs 59.7%). Over the past eight quarters, Catheter Precision, Inc.'s revenue compounded faster (70.4% CAGR vs 44.4%).

Sharps Rifle Manufacturing Company was the manufacturer of the Sharps Rifle. The company was organized by Samuel Robbins and Richard S. Lawrence as a holding company in Hartford, Connecticut, on October 9, 1851 with $100,000 in capital. Despite Sharps departing from the company bearing his name, Sharps Rifle Manufacturing Company produced over 100,000 rifles, but it dissolved in 1881 with the widespread use of repeating rifles.

Namiki Precision Jewel Co., Ltd. is a Japanese component manufacturing company based in Tokyo, Japan. The company was founded in 1939 as a manufacturer of synthetic sapphire jewel bearings for electrical measuring instruments. Namiki supplies industrial jewel parts, dc coreless and dc brushless motors, multi-functional vibration components, precision gearheads, medical equipment, watch exterior parts, Analog Record-related Products and other precision components. Namiki merged with its affil...

STSS vs VTAK — Head-to-Head

Bigger by revenue
VTAK
VTAK
2.8× larger
VTAK
$238.0K
$83.6K
STSS
Growing faster (revenue YoY)
STSS
STSS
+158.2% gap
STSS
217.9%
59.7%
VTAK
Higher net margin
VTAK
VTAK
123535.9% more per $
VTAK
-2427.7%
-125963.6%
STSS
Faster 2-yr revenue CAGR
VTAK
VTAK
Annualised
VTAK
70.4%
44.4%
STSS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
STSS
STSS
VTAK
VTAK
Revenue
$83.6K
$238.0K
Net Profit
$-105.3M
$-5.8M
Gross Margin
-1398.7%
91.6%
Operating Margin
-122747.9%
-4143.3%
Net Margin
-125963.6%
-2427.7%
Revenue YoY
217.9%
59.7%
Net Profit YoY
-6151.0%
-2.7%
EPS (diluted)
$-4.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STSS
STSS
VTAK
VTAK
Q4 25
$238.0K
Q3 25
$83.6K
$226.0K
Q2 25
$222.7K
$212.0K
Q1 25
$-627.0K
$143.0K
Q4 24
$149.0K
Q3 24
$96.0K
Q2 24
$5.3K
$93.0K
Q1 24
$19.0K
$82.0K
Net Profit
STSS
STSS
VTAK
VTAK
Q4 25
$-5.8M
Q3 25
$-105.3M
$-2.3M
Q2 25
$3.6M
$-5.1M
Q1 25
$1.9M
$-4.0M
Q4 24
$-5.6M
Q3 24
$-4.1M
Q2 24
$-2.1M
$-4.2M
Q1 24
$-982.4K
$-2.7M
Gross Margin
STSS
STSS
VTAK
VTAK
Q4 25
91.6%
Q3 25
-1398.7%
92.0%
Q2 25
-463.4%
93.4%
Q1 25
92.3%
Q4 24
92.6%
Q3 24
89.6%
Q2 24
82.8%
Q1 24
93.9%
Operating Margin
STSS
STSS
VTAK
VTAK
Q4 25
-4143.3%
Q3 25
-122747.9%
-1336.7%
Q2 25
-1349.8%
-2210.4%
Q1 25
322.5%
-2500.0%
Q4 24
-2047.7%
Q3 24
-2978.1%
Q2 24
-36329.4%
-2921.5%
Q1 24
-9693.8%
-3190.2%
Net Margin
STSS
STSS
VTAK
VTAK
Q4 25
-2427.7%
Q3 25
-125963.6%
-996.0%
Q2 25
1598.1%
-2409.9%
Q1 25
-307.6%
-2828.7%
Q4 24
-3777.2%
Q3 24
-4291.7%
Q2 24
-39756.6%
-4537.6%
Q1 24
-5164.2%
-3262.2%
EPS (diluted)
STSS
STSS
VTAK
VTAK
Q4 25
Q3 25
$-4.33
Q2 25
$3.58
Q1 25
$38.62
Q4 24
Q3 24
Q2 24
$-643.64
Q1 24
$-347.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STSS
STSS
VTAK
VTAK
Cash + ST InvestmentsLiquidity on hand
$10.5M
$88.0K
Total DebtLower is stronger
$3.1M
Stockholders' EquityBook value
$433.2M
$7.1M
Total Assets
$444.0M
$15.9M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STSS
STSS
VTAK
VTAK
Q4 25
$88.0K
Q3 25
$10.5M
$1.1M
Q2 25
$8.3M
$838.0K
Q1 25
$11.9M
$450.0K
Q4 24
$2.9M
Q3 24
$1.3M
Q2 24
$1.5M
$16.0K
Q1 24
$1.2M
$1.5M
Total Debt
STSS
STSS
VTAK
VTAK
Q4 25
$3.1M
Q3 25
$1.5M
Q2 25
$1.5M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
STSS
STSS
VTAK
VTAK
Q4 25
$7.1M
Q3 25
$433.2M
$6.8M
Q2 25
$14.5M
$6.8M
Q1 25
$10.1M
$7.9M
Q4 24
$11.8M
Q3 24
$12.8M
Q2 24
$7.2M
$14.3M
Q1 24
$6.9M
$18.5M
Total Assets
STSS
STSS
VTAK
VTAK
Q4 25
$15.9M
Q3 25
$444.0M
$25.5M
Q2 25
$17.1M
$25.6M
Q1 25
$18.9M
$24.8M
Q4 24
$27.8M
Q3 24
$26.7M
Q2 24
$9.9M
$26.3M
Q1 24
$9.8M
$28.0M
Debt / Equity
STSS
STSS
VTAK
VTAK
Q4 25
0.44×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STSS
STSS
VTAK
VTAK
Operating Cash FlowLast quarter
$-7.4M
$-1.5M
Free Cash FlowOCF − Capex
$-8.8M
FCF MarginFCF / Revenue
-10559.0%
Capex IntensityCapex / Revenue
1724.5%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STSS
STSS
VTAK
VTAK
Q4 25
$-1.5M
Q3 25
$-7.4M
$-2.2M
Q2 25
$-1.9M
$-2.3M
Q1 25
$-2.5M
$-2.3M
Q4 24
$-2.9M
Q3 24
$-2.8M
Q2 24
$-1.6M
$-1.7M
Q1 24
$-1.9M
$-1.9M
Free Cash Flow
STSS
STSS
VTAK
VTAK
Q4 25
Q3 25
$-8.8M
Q2 25
$-3.8M
$-2.3M
Q1 25
$-2.5M
$-2.3M
Q4 24
Q3 24
Q2 24
$-1.7M
$-1.7M
Q1 24
$-1.9M
$-2.0M
FCF Margin
STSS
STSS
VTAK
VTAK
Q4 25
Q3 25
-10559.0%
Q2 25
-1694.8%
-1070.8%
Q1 25
405.3%
-1642.0%
Q4 24
Q3 24
Q2 24
-31313.6%
-1873.1%
Q1 24
-9946.7%
-2395.1%
Capex Intensity
STSS
STSS
VTAK
VTAK
Q4 25
0.0%
Q3 25
1724.5%
0.0%
Q2 25
839.3%
3.3%
Q1 25
-14.4%
7.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
312.1%
48.4%
Q1 24
15.0%
26.8%
Cash Conversion
STSS
STSS
VTAK
VTAK
Q4 25
Q3 25
Q2 25
-0.54×
Q1 25
-1.27×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons